Daniela is a Clinical Research Associate I at Proxima Clinical Research, a contract research organization that serves the emerging drug and medical device industries. 

Daniela has previously worked as a clinical research coordinator in an infectious diseases research institute, focusing on conducting phase II-III drug and observational clinical trials related to COVID-19 and HIV. Daniela also has experience in laboratory coordination and management. She is originally from Venezuela and received a B.S. as Medical Technologist from University of Carabobo, and a M.S. in Basic Immunology from Central University of Venezuela.

University of Carabobo: Medical Technologist, B.S.

Central University of Venezuela: Basic Immunology, M.S.

Proxima Clinical Research, Inc., Houston, Texas
Clinical Research Associate I

Pierone Research Institute – Whole Family Health Center, Vero Beach, FL
Research Coordinator‍

Medical Data System, Inc., Melbourne, FL
Support Supervisor ‍

Indian River State College, Fort Pierce, FL
Adjunct Professor‍

‍Calicanto Clinic, Maracay, Venezuela
Laboratory Coordinator‍

University of Carabobo, Maracay, Venezuela
Assistant Professor‍

Immunology Institute of Central University of Venezuela, Caracas, Venezuela
Research Assistant‍

Immunology Institute of Central University of Venezuela, Caracas, Venezuela
Laboratory Coordinator‍

Guadalupe Laboratory, Maracay, Venezuela
Medical Technologist

‍

Ms. Martinez has received the following honors:

Basic Medical Research Award “Dr. José María Vargas” 2017. Faculty of Medicine. Central University of Venezuela.

Honorable Mention in Master Dissertation 2014. “IL-4, ADAM33, CTLA-4 and IL-1RA polymorphisms in Venezuelan patients with asthma and COPD”.

Ms. Martinez has played an important role in the development of the following medical products:‍

1. Drugs for acute COVID-19 for high-risk patients to develop severe COVID-19
2. Drug for acute SARS-CoV-2 infection in patients with comorbidities
3. Observational trial for acute COVID-19
4. Observational trial for immune response produced by COVID-19 vaccines (Pfizer, ModeRNA, and Janssen)
5. Specimen collection for acute and post-acute SARS-CoV-2 infection
6. Emergency Use Authorization of Bamlanivimab for acute COVID-19
7. Emergency Use Authorization of Bamlanivimab and Etesivimab for acute COVID-19
8. Emergency Use Authorization of Casirivimab-Indevimab (REGEN-COV™) for acute COVID-19
9. Specimen collection for patients infected with HIV  

‍

Ms. Martinez has contributed to the following peer-reviewed publications:  ‍

Single nucleotide polymorphisms V4 and T1 of the ADAM33 gene in Venezuelan patients with asthma or COPD. Martínez, D. et al. Investigación clínica (2016); 57(2): 176-187.

Single nucleotide polymorphisms of V4 and T1 of the ADAM33 gene in patients with asthma and COPD. Martínez, D. et al. 23rd Scientific Congress “Dr. Francisco de Venanzi”. 2014.

Genetic Polymorphisms of IL-4, CTLA-4 and IL-1Ra in Venezuelan Mestizo Patients with Asthma or COPD. Martínez, D. et al. T.29. FOCIS 2013, Abstract Supplement. Boston, MA.

Genotype Frequencies and Mutations in "A" Determinant of Hepatitis B Surface Antigen in patients with Hepatitis B. Martínez, D. and Marrero, C. 9th Research Congress “Prof Ledia Triana”. 2007